Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)
Carrieri, P.; Campanella, G.; Mandarini, A.; Orefice, G.; Buscaino, G.A.
Acta Neurologica 31(5): 558-564
1976
ISSN/ISBN: 0001-6276 PMID: 1015382 Document Number: 108735
Document emailed within 1 workday
Related Documents
Buscaino, G.A.; Mandarini, A.; Campanella, G.; Carrieri, P.; Orefice, G. 1976: Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes Acta Neurologica 31(5): 565-570Véron, J.P.; Mérienne, L. 1972: The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine La Nouvelle Presse Medicale 1(8): 537-539
Specchio, L.M.; Puca, F.M.; Livrea, P.; Genco, S.; Bandiera, L.; Di Reda, L. 1976: Repeated arousal during non-REM sleep in normal humans. Changes in anxiety, depression and aggressiveness and HVA and 5-HIAA levels in the lumbar cerebrospinal fluid Bollettino della Societa Italiana di Biologia Sperimentale 52(11): 788-793
Molina-Holgado, E.; Dewar, K.M.; Descarries, L.; Reader, T.A. 1994: Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine Journal of Pharmacology and Experimental Therapeutics 270(2): 713-721
Veszprémi, B.; Hartmann, G.; Szabó, I.; Vereczkey, G.; Arany, A. 1993: Dopamine, noradrenaline and serotonin levels in amniotic fluid during the second trimester in normal and pathologic pregnancy Orvosi Hetilap 134(14): 745-747
Carrieri, P.; Mandarini, A.; Campanella, G. 1975: HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data Acta Neurologica 30(5): 449-454
Sasaki, T.; Sugawara, K.; Furuta, K.; Shimoda, K. 1975: Studies on revaluation of determination of biochemical components in urine and cerebrospinal fluid (2)-Establishment of optimal conditions for protein determination in urine and cerebrospinal fluid by Meulemans' method Rinsho Byori. Japanese Journal of Clinical Pathology 23(8): 630-634
Albert, J.M.; Palaic, D.; Tetreault, L.; Panisset JC DHAITI, G.; Desaty, J. 1970: Effect of thioproperazine on 5-HIAA content in urine and cerebrospinal fluid of chronic schizophrenic patients Diseases of the Nervous System 31(Suppl): 140-144
Fukuda, H.; Nakamura, S.; Hara, K.; Udaka, F.; Kameyama, M. 1989: Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases Rinsho Shinkeigaku 29(9): 1192-1194
Ramu, A.; Fusner, J.E.; Blaschke, T.; Glaubiger, D.L. 1978: Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs Cancer Treatment Reports 62(10): 1465-1470
Schulz, D.; Rothenhöfer, C. 1979: Anatomical structures, physiology and pathophysiology of cerebrospinal fluid metabolism; a review for an understanding of cerebrospinal fluid findings Fortschritte der Medizin 97(40): 1814-1820
Tagami, T. 1970: Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern Nippon Ganka Gakkai Zasshi 74(9): 1129-1135
Döbler, K.; Nolte, H. 1990: Do elevated blood and cerebrospinal fluid glucose levels and other factors modify the density of cerebrospinal fluid and the spread of isobaric spinal anesthesia? Regional-Anaesthesie 13(4): 101-107
Deluca, D.C.; Angel, C.; Murphree, O.D. 1977: Effects of amphetamine and chlordiazepoxide on probenecid-induced accumulation of acidic metabolites in the cerebrospinal fluid of the dog Biological Psychiatry 12(4): 577-582
Schnell, R.; Jegge, S.; Rieder, H.P. 1983: Determination of protein in cerebrospinal fluid: comparison of the Coomassie-Blue method and the Cu-Folin differential test Journal of Clinical Chemistry and Clinical Biochemistry 21(3): 151-155
Szafrańska, M. 1982: Changes in the levels of immunoglobulins G, A and M in the cerebrospinal fluid and serum of children with cerebrospinal meningitis. I. Serous cerebrospinal meningitis Pediatria Polska 57(5-6): 365-369
Moncrieff, J. 1989: Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection Journal of Chromatography 496(2): 269-278
Jimerson, D.C.; Post, R.M.; Skyler, J.; Bunney, W.E. 1976: Prolactin in cerebrospinal fluid and dopamine function in man Journal of Pharmacy and Pharmacology 28(11): 845-846
Jiang, S.; Chen, X.; Liao, W. 1998: Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics Hunan Yi Ke da Xue Xue Bao 23(2): 155-156
Hösli, L.; Hösli, E. 1987: Receptors for dopamine and serotonin on astrocytes of cultured rat central nervous system Journal de Physiologie 82(4): 191-195